Share Name Share Symbol Market Type Share ISIN Share Description
Shire Plc LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -17.50p -0.39% 4,515.00p 4,515.50p 4,516.00p 4,550.00p 4,427.50p 4,550.00p 530,343 13:38:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 11,224.6 3,149.2 348.7 12.6 41,067.64

Shire Share Discussion Threads

Showing 5251 to 5275 of 5275 messages
Chat Pages: 211  210  209  208  207  206  205  204  203  202  201  200  Older
DateSubjectAuthorDiscuss
18/9/2018
10:38
Value of the Takeda offer a few minutes ago, based on live fx rates, was 5,017p made up of 2,311p in cash & 2,706p in shares. With current share price of 4,482p the current Shire share price would need to rise by 11.93% to match. From the original offer valued at 4901p, we've lost 106p in value due to fall in value of Takeda shares but gained 222p because of favourable fx movements on both the cash and share elements. Takeda share price (Yen) = 4737 £:$ = 1.31246 £:Yen = 146.89
redtom1
18/9/2018
08:20
That's takeda up about 7% in the past week.
dwinn78
14/9/2018
10:24
Takeda more or less confirmed they will look to assets disposals to cut down debt immediately on taking control next year.Targeting at least $5 billion in the first instance. This of course makes total sense and was no doubt factored in all along.
romeike
13/9/2018
10:55
Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt Japanese firm also assesses divestment of Natpara medicine Disposals could raise about $4 billion to $5 billion hTTps://www.bloomberg.com/news/articles/2018-09-13/takeda-is-said-to-weigh-sale-of-shire-eye-care-drug-to-cut-debt
fangorn2
11/9/2018
16:52
Exactly. Haven't heard much dissent from the idea that Takeda need to do something radical. That is why they brought in Weber in the first place. At the end of the day they have no near or mid term pipeline and they are overexposed to their home market.
romeike
11/9/2018
07:04
A strong recovery in takeda overnight. I would have thought that if the minority takeda shareholders want to scupper this deal, their efforts would be better directed at getting someone else to outbid them for shp.
pete160
10/9/2018
18:24
not out of the woods yet it seems Https://www.fiercepharma.com/pharma/takeda-founder-family-alarms-ceo-christophe-weber-disastrous-shire-buyout-deal?mkt_tok=eyJpIjoiWkdJek1EUXdOVFkyTnpaaiIsInQiOiJTMmdhUG1KdWtyYkpjN0JLMFpRWlkycjQyVlBlckwraGlQRXdsZ1ZUMWY4VWlmUXIwakNua0N1bEJlRThQSnRFM3QzQndESzJQdTR0RllpXC9LWkJOV1p2MkZrbGVRRkpnY3liT1RTN2tYWmp4SitXSmM4d280R0NWRW9mbll4aGcifQ%3D%3D&mrkid=67999416
swedeee
10/9/2018
15:03
Also seems that the small minority of the family, none of whom presumably actually have business experience, have not proposed any alternative plan to the CEO as to how to deal with the issues that the Shire deal resolves for Takeda, or any suggestions on how much it would cost Takeda to build a development pipeline from scratch.
romeike
10/9/2018
13:36
Problem is cash in dollars, paper in Yen, shares quoted sterling, does not suit everyone, my guess it won't happen.
montyhedge
10/9/2018
08:37
The article concludes by saying few analysts see the deal being derailed.
steeplejack
09/9/2018
11:52
From my brief reading of the Sunday Times pieces - both front page and inside, I don't think that any of it is new news. The gist of the story seems to be that a small minority of the Takeda family don't like that their original company is changing through the purchase of SHP. However, even the article says that this involves only a small minority of the family, who are minority shareholders in any case, that their initial stirrings to try to block the deal have come to nought and that they are unlikely to find significant support to make any difference going forward. The article highlights the dangers (to Takeda) of the debt being taken on to fund the deal but then also mentions that a significant proportion of the purchase price is being funded via the issuing of new shares. My opinion is that I very much doubt that this will derail the takeover. I see the main threat to the deal completing being an overall market correction of 25%+ in which case all deals will look to be pulled or renegotiated. Despite taking a slice of profits earlier on I still have a disproportionately large slice of my portfolio in SHP but I'm toying with the idea of buying more due to the 14% gap in the potential prices and also the reducing timeframe for the deal to complete. Regardless of the Takeda family comments, in my opinion the risks of the deal not completing - relative to the potential upside in price, is reducing.
pete160
09/9/2018
08:20
https://www.thetimes.co.uk/edition/business/japan-s-takeda-family-brands-shire-deal-a-disaster-29gxn02f5
dwinn78
07/9/2018
14:27
What's your thoughts on the recent sharp drop in takeda red?
dwinn78
07/9/2018
11:59
Value of the Takeda offer a few minutes ago, based on live fx rates, was 4,875p made up of 2,331p in cash & 2,545p in shares. With current share price of 4,288p the current Shire share price would need to rise by 13.69% to match. From the original offer valued at 4901p, we've lost 319p in value due to fall in value of Takeda shares but gained 293p because of favourable fx movements on both the cash and share elements. Takeda share price (Yen) = 4374 £:$ = 1.30136 £:Yen = 144.221
redtom1
07/9/2018
06:00
Takeda currently down 3%. Shire will be under pressure today if it doesn't recover.
dwinn78
06/9/2018
18:20
"Shire retreated as it announced the acquisition of Switzerland's Sanaplasma AG for an undisclosed sum and as its stock went ex-dividend" Slim Divi though... Anyone heard more about the acquisition?
fangorn2
06/9/2018
08:20
Nope , vote still to happen .
dwinn78
06/9/2018
08:04
Out of touch on Shire since I sold out, has both group of shareholders agreed bid ?
montyhedge
05/9/2018
11:36
Value of the Takeda offer a few minutes ago, based on live fx rates,was 5,042p made up of 2,367p in cash & 2,675p in shares. With current share price of 4,410p the current Shire share price would need to rise by 14.33% to match. From the original offer valued at 4901p, we've lost 214p in value due to fall in value of Takeda shares but gained 355p because of favourable fx movements on both the cash and share elements. Takeda share price (Yen) = 4558 £:$ = 1.28115 £:Yen = 142.993
redtom1
05/9/2018
10:49
For what it is worth, I've been a Shire shareholder since it was a really small company and I'm holding for this deal. Takeda are getting excellent value and they know it, meanwhile Shire continues to deliver strong sales performance. Investors with significant holdings will want to hold for the paper for tax purposes and also to benefit from the improving Takeda shareprice and what I expect to be increasingly favourable FX given the likely shenanigans ahead for GBP.
romeike
05/9/2018
10:36
What's the value of the deal today red?
dwinn78
31/8/2018
09:39
Shire, meanwhile, said it had completed the sale of its oncology franchise to Servier for $2.4bn. Its shares were broadly unchanged. "Some petty cash!" :)
fangorn2
30/8/2018
14:11
Can it hold on to 45?....
toffeeman
29/8/2018
09:35
Value of the Takeda offer a few minutes ago, based on live fx rates, was 5,048p made up of 2,356p in cash & 2,692p in shares. With current share price of 4,540p the current Shire share price would need to rise by 11.19% to match. From the original offer valued at 4901p, we've lost 193p in value due to fall in value of Takeda shares but gained 340p because of favourable fx movements on both the cash and share elements. Takeda share price (Yen) = 4594 £:$ = 1.2876 £:Yen = 143.153
redtom1
29/8/2018
09:25
I would bail out at a 5% discount. But I'm not sure that we will get to see that low a level until the bitter end if at all. Personally I may well take the Takeda Paper, particularly if it means realising the additional value. Shire is performing well so it will enhance Takeda's earnings and I think the markets may well embrace the deal (initially). However, I suspect that the integration will be more problematic down the line so I would not hold onto to Takeda for more than a year or so. I know a lot of people think that the additional Takeda Paper will trigger a mass selling (ie by people who don't really want it) but in reality this will not be material. PPs will sell but this is small beer in scheme of things. Institutions on the whole will want to keep hold of stock in the enlarged Group. Japanese holders that are unhappy are already bailing out so by mid next year I think the shareholder base will be positive towards the deal and that Takeda share price will actually rise rather than fall as most of the uncertainty will have gone. All in my opinion of course.
redtom1
Chat Pages: 211  210  209  208  207  206  205  204  203  202  201  200  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180920 12:53:45